PeptideDB

3,7,4'-Trihydroxyflavone 2034-65-3

3,7,4'-Trihydroxyflavone 2034-65-3

CAS No.: 2034-65-3

3,7,4'-Trihydroxyflavone is a flavonoid with DNA chain-breaking activity extracted from Rhus javanica var. roxburghiana.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

3,7,4'-Trihydroxyflavone is a flavonoid with DNA chain-breaking activity extracted from Rhus javanica var. roxburghiana.

Physicochemical Properties


Molecular Formula C15H10O5
Molecular Weight 270.2369
Exact Mass 270.053
CAS # 2034-65-3
PubChem CID 5281611
Appearance Light yellow to yellow solid powder
Density 1.579g/cm3
Boiling Point 539.7ºC at 760mmHg
Melting Point 310-311ºC
Flash Point 210.6ºC
Vapour Pressure 1.76E-12mmHg at 25°C
Index of Refraction 1.747
LogP 2.576
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 1
Heavy Atom Count 20
Complexity 422
Defined Atom Stereocenter Count 0
InChi Key OBWHQJYOOCRPST-UHFFFAOYSA-N
InChi Code

InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)15-14(19)13(18)11-6-5-10(17)7-12(11)20-15/h1-7,16-17,19H
Chemical Name

3,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets DNA
ln Vitro In the presence of Cu(II), 3,7,4'-Trihydroxyflavone induced breakage of supercoiled plasmid pBR322 DNA. [1]
Cu(I) was confirmed as an essential intermediate in the DNA strand-scission process mediated by 3,7,4'-Trihydroxyflavone and Cu(II), which was verified using the Cu(I)-specific sequestering reagent neocuproine. [1]
The Cu(II)-mediated DNA scission induced by 3,7,4'-Trihydroxyflavone was inhibited by the addition of catalase, while DNA strand breakage was observed upon the addition of KI and superoxide dismutase (SOD). [1]
3,7,4'-Trihydroxyflavone could induce the production of H₂O₂ and superoxide anion in the presence of Cu(II), leading to subsequent oxidative damage of DNA. [1]
Cell Assay DNA strand-scission activity assay: Supercoiled plasmid pBR322 DNA was incubated with 3,7,4'-Trihydroxyflavone in the presence of Cu(II) to detect whether the drug could cause DNA breakage. [1]
Cu(I) intermediate verification assay: The Cu(I)-specific sequestering reagent neocuproine was added to the reaction system of 3,7,4'-Trihydroxyflavone, Cu(II), and pBR322 DNA to confirm the role of Cu(I) as an essential intermediate in the DNA strand-scission process. [1]
Reactive oxygen species (ROS) related assay: Catalase, KI, and superoxide dismutase (SOD) were separately added to the reaction system of 3,7,4'-Trihydroxyflavone, Cu(II), and pBR322 DNA to investigate the types of ROS involved in the DNA oxidative damage induced by the drug. [1]
ADME/Pharmacokinetics Metabolism / Metabolites
Resokaempferol has known human metabolites that include (2S,3S,4S,5R)-6-[4-(3,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.
References

[1]. Flavonoids with DNA strand-scission activity from Rhus javanica var. roxburghiana. Fitoterapia. 2008 Jan;79(1):32-6. Epub 2007 Aug 9.

Additional Infomation 3,4',7-Trihydroxyflavone is a hydroxyflavan.
3,7,4'-Trihydroxyflavone has been reported in Erythrina fusca, Anthyllis vulneraria, and other organisms with data available.
3,7,4'-Trihydroxyflavone is a flavonoid isolated from the stems of Rhus javanica var. roxburghiana. [1]

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~370.04 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (9.25 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (9.25 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (9.25 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.7004 mL 18.5021 mL 37.0041 mL
5 mM 0.7401 mL 3.7004 mL 7.4008 mL
10 mM 0.3700 mL 1.8502 mL 3.7004 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.